Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study
Rochelle Bagatell, Robin Norris, Ashish M. Ingle, Charlotte Ahern, Stephan Voss, Elizabeth Fox, Anthony R. Little, Brenda J. Weigel, Peter C. Adamson, Susan Blaney
Dive into the research topics of 'Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study'. Together they form a unique fingerprint.